I'm in Ontario, Canada.
I'm on cannabinoid-therapy for a chronic pain and a seizure condition, which means I use medical cannabis. The insurance company already clear that, and I get ~$300 / month in cannabis related expensive returned at 80%, which equates to a ~$250 reimbursement. That's been signed off, and I have the forms to prove it. I have 18 doctors treating me, that's not a typo, 18 doctors. I have to travel in February for my wedding out of country, and so my doctors prescribed Sativex, which in Canada has DIN (Drug Identification Number), and goes through a different channel to be approved by insurance.
The first, and second time I submitted my prior approval forms, denied with the reasoning, and I'm not making this up, these are direct quotes:
1. The Canadian medical profession doesn't broadly accept it.
2. Health Canada doesn't approve of it for this type of treatment.
3. This drug doesn’t meet your plan’s criteria for approval (prior authorization).
4. You may want to talk with your physician for alternate treatment options.
Cannabis isn't accepted broadly by the Canadian medical community? It's widely accepted, and considered effective for certain narrow conditions. Most doctors won't prescribe it, but I have rarely met a doctor who won't accept it as a possible solution. Health Canada doesn't approve it? They do, with confusing and circular language, but, they do accept its medical benefits, again, for narrow conditions. The drug must meet the plans criteria, I'm already using a cannabinoid medication, cannabis, which they signed off on. The last point is the most annoying, Sativex is the only medication that is a natural cannabinoid medication, which also has a DIN assigned, specifically for Chronic Neuropathic Pain Disorders. That was followed up with statements that a consultant medical professional had looked up all my information, paper work, medical history and conditions, and determined Sativex was not suitable, and other medications existed.
When I pushed back slightly, the following happened:
1. We can't give you the contact information for the consultant.
2. They used all the available medical information provided.
3. Sativex has not been approved for your conditions (it literally has according to the HC monograph).
4. Cannabinoid-therapy would not consider effective in this circumstance (I'm already using it and approved).
That caused several rounds of phone calls and emails which went nowhere, so I email the CEO, COO, CRO, CPO, CHRO, EVPs, SVPs, JVPs, and head legal counsel for the company. Submitted the same 40-page form submission, which had extensive medical history, and guess what? It got approved, which has the only possible conclusion that the first and second submission were never read by a human.
How do they possibly claim that cannabis wouldn't be effective for chronic pain and seizures? The two most known, accepted, and widely agreed upon uses in a medical setting are seizures and pain. Pair that with the fact I'm already using a cannabinoid-therapy, and Sativex is literally THCd9 and CBD in a formulation accepted by HC and issued a DIN number. Taking all of that into account, and seeing my previous approvals, no human looked at anything in that approval discourse. What did happen? AI read the application, then looked up the old outdated monograph, and concluded that I don't fit the narrow, one off exception, for Sativex approval, dropped years ago. It used to only be approved for MS related chronic neuropathic pain, which HC had to drop after failing to define how MS chronic neuropathic pain was different from any other undifferentiated form of chronic neuropathic pain. The monograph now states it can treat or help with chronic neuropathic pain, but you'd only know that if you bothered to read the monograph listing, which the AI didn't do, and no human intervined with, until I cause a fuss.